Home524494 • BOM
add
IPCA Laboratories Ltd
Nakaraang pagsara
₹1,372.65
Sakop ng araw
₹1,337.00 - ₹1,368.40
Sakop ng taon
₹1,060.95 - ₹1,757.65
Market cap
339.68B INR
Average na Volume
6.86K
P/E ratio
46.01
Dividend yield
0.30%
Primary exchange
NSE
Mga balita tungkol sa merkado
Barron's
1 oras ang nakalipas
Dow, Oil Edging Up as Global Markets Await Iran Response to U.S. Attacks
0.22%
1.12%
0.083%
0.034%
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 22.47B | 10.46% |
Gastos sa pagpapatakbo | 12.10B | 43.03% |
Net na kita | 678.20M | 13.81% |
Net profit margin | 3.02 | 3.07% |
Kita sa bawat share | 8.74 | 12.92% |
EBITDA | 4.28B | 36.50% |
Aktuwal na % ng binabayarang buwis | 49.30% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 11.08B | 29.66% |
Kabuuang asset | 117.61B | 5.94% |
Kabuuang sagutin | 33.72B | -0.06% |
Kabuuang equity | 83.88B | — |
Natitirang share | 254.01M | — |
Presyo para makapag-book | 5.02 | — |
Return on assets | — | — |
Return on capital | 8.62% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 678.20M | 13.81% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients. Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules. Wikipedia
Itinatag
Okt 19, 1949
Website
Mga Empleyado
17,335
